Give Online: Help shape patient care for generations to come.
Cleveland Clinic Logo


Request an Appointment

Cancer Answer Line:

M-F 8 a.m. - 4:30 p.m. ET

Expand Content

Cancer Clinical Trials Results

CASE 5214 15-166 A Phase II Study of Second-Line Therapy with Regorafenib Plus Gemcitabine in Metastatic Pancreatic Cancer Fairview, Hillcrest, Independence, Main Campus Phase 2Pancreas
CASE 6Y14 15-465 Integrated 3D x-ray and ultrasound Guided Radiation Therapy of Soft Tissue Target Main Campus  Liver, Pancreas, Prostate
CASE 921212-1317 Outcomes Registry of Patients with Pancreatic Cancer Undergoing Definitive Treatment at Cleveland Clinic Main Campus  Pancreas
EA 2142 16-073 Randomized Phase II Study of Cisplatin and Etoposide versus Temozolomide and Capecitabine in Patients with Advanced G3 Non-Small Cell Gastroenteropancreatic Neuroendocrine Carcinomas Fairview, Hillcrest, Independence, Main Campus, Mansfield, North Coast Cancer, South Pointe, Strongsville, Wooster Phase 2Pancreas
OMP 1215 15-820 A 3-Arm Phase 2 Double-Blind Randomized Study of Gemcitabine, Abraxane┬« Plus Placebo versus GemcitabIne, Abraxane┬« plus 1 or 2 Truncated Courses of Demcizumab in Subjects with 1st-Line Metastatic Pancreatic Ductal Adenocarcinoma Fairview, Hillcrest, Main Campus Phase 2Pancreas
RTOG 084814-1113 A Phase II-R and A Phase III Trial Evaluating both *Erlotinib (PH II-R) and Chemoradiation (PH III) as Adjuvant Treatment for Patients with Resected Head of Pancreas Adenocarcinoma Beachwood, Fairview, Hillcrest, Independence, Mansfield, North Coast Cancer, Strongsville, WoosterStage 3Phase 2, Phase 3Pancreas
SWOG 1505 15-1472 A Randomized Phase II Study of Perioperative mFolfirinox Versus Gemcitabine/Nab-Paclitaxel as Therapy for resectable Pancreatic Adenocarcinoma Fairview, Florida Weston, Hillcrest, Independence, Main Campus, Mansfield, North Coast Cancer, South Pointe, Strongsville, Wooster Phase 2Pancreas

Cancer Answers & Appointments

Speak with a cancer nurse specialist for appointment assistance and for answers to your questions about cancer locally at 216.444.7923 or toll-free 1.866.223.8100.

Monday through Friday from 8 a.m. – 4:30 p.m. (ET).


Resources for medical professionals

  • Outpatient appointment referrals: 216.444.7923 or 866.223.8100
  • Inpatient hospital transfers: 800.553.5056
  • Referring Physician Concierge: 216.444.6196 or 216.312.4910.

Clinical Trials

Search available cancer clinical trials by disease, hospital, phase or number.